Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection
2017
Presentation of Childhood Brucellosis in Western Greece
2006
Complications of Brucella Infection among Adults: An 18-Year Retrospective Evaluation
2006
Zygomycosis in HIV‐positive patients: a review of the literature
1996
Incidence of Antibiotic Resistance in Listeria Species
1995 StandoutNobel
A Comparative Study of Pyogenic and Tuberculous Spondylodiscitis
2010
Diagnostic Ultrastructure ofListeria monocytogenesin Human Central Nervous Tissue
1993
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
2011
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Tratamiento directamente observado de la infección tuberculosa latente: estudio comparativo de dos pautas con isoniacida
2003
Brucella infection in total hip replacement: Case report and review of the literature
2004
Brucellosis as a cause of acute febrile illness in Egypt
2007
From the discovery of the Malta fever?s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis
2005 Standout
New Consensus Guidelines from the Clinical and Laboratory Standards Institute for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria
2006 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Botulinum Toxin as a Biological Weapon
2001 Standout
Brucellosis: an Overview
1997 Standout
Non-pyogenic infections of the spine
2010
Use of sulesomab in the diagnosis of brucellar spondylitis
2004
Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
2004
The Impact of Prebiopsy Antibiotics on Pathogen Recovery in Hematogenous Vertebral Osteomyelitis
2011
Increasing incidence of pyogenic spondylodiscitis: A 14-year population-based study
2013
Application of a Polymerase Chain Reaction Enzyme Immunoassay in Peripheral Whole Blood and Serum Specimens for Diagnosis of Acute Human Brucellosis
2004
Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran
2004
Clinical Findings, Therapeutic Approach, and Outcome of Brucellar Vertebral Osteomyelitis
2007
Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter
1995
Spondylodiscitis: update on diagnosis and management
2010
Development and evaluation of real-time polymerase chain reaction assays on whole blood and paraffin-embedded tissues for rapid diagnosis of human brucellosis
2007
The new global map of human brucellosis
2006 Standout
Challenges in Brucella bacteraemia
2007
Brucellosis
2005 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
The Science of Antibiotic Discovery
2020 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
TargetingBrucella melitensiswith polymeric nanoparticles containing streptomycin and doxycycline
2009
Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
2004 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Acute brucellosis: presentation, diagnosis, and treatment of 144 cases
2006
Application of a user-friendly Brucella-specific IgM and IgG antibody assay for the rapid confirmation of Rose Bengal-positive patients in a hospital in Iran
2005
Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials
2008
Brucellosis: A re-emerging zoonosis
2009 Standout
Treatment of latent infection withMycobacterium tuberculosis: update 2010
2010
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Clinical Features, Complications and Treatment Outcome of Childhood Brucellosis in Central Greece
2002
Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003
2005
Prospective, randomized, two-arm controlled study to evaluate two interventions to improve adherence to antiretroviral therapy in Spain
2010
Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]
2006
Clinical Assessment and Medical Treatment of Spine Infections
2006
Massive renal infarction due to mucormycosis in an AIDS patient
1992
Bloodstream Infections
2008
Brucellar spondylodiscitis: magnetic resonance imaging features with conventional sequences and diffusion-weighted imaging
2010
Brucellosis in San Diego
2005
Assessment of Magnesium Status in Patients with Bronchial Asthma
2000
Biological weapons
2006
Antimicrobial chemotherapy of human infection due toListeria monocytogenes
1995
Fluorescence polarization assay for diagnosis of human brucellosis
2003
Hematogenous Spinal Infection in Central Greece
2009
Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature
2009 Standout
Brucellosis in patients infected with the human immunodeficiency virus
1998
BrucellaProsthetic Joint Infection: A Report of 3 Cases and a Review of the Literature
2003
Scintigraphic findings in osteoarticular brucellosis
2005
Increased Risk of Meningitis and Bacteremia Due to Listeria monocytogenes in Patients with Human Immunodeficiency Virus Infection
1993
Clinical recognition and management of patients exposed to biological warfare agents
1997
Brucellosis: a worldwide zoonosis
2001
Reduced intracellular magnesium concentrations in asthmatic patients
1999
Fungi, Mycobacteria, Zoonotic and Other Organisms in Prosthetic Joint Infection
2006
Tularemia as a Biological Weapon
2001 Standout
Human brucellosis
2007 Standout
Characteristics of B. melitensis versus B. abortus bacteraemias
2004
Comparison between doxycycline–rifampin–amikacin and doxycycline–rifampin regimens in the treatment of brucellosis
2006
Global Burden of Human Brucellosis: A Systematic Review of Disease Frequency
2012 Standout
Clinical and MRI findings of brucellar spondylodiscitis
2007
Complications Associated with Brucella melitensis Infection: A Study of 530 Cases
1996 Standout
Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation
2006
Successful management of Brucellamellitensis endocarditis with combined medical and surgical approach
2001
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Age and Duration of Disease as Factors Affecting Clinical Findings and Sacroiliitis in Brucellosis
2007
Brucellosis and International Travel
2004
Evaluation of the clinical presentations in neurobrucellosis
2006
Infective endocarditis
2004 Standout
Acute Bacterial Meningitis in Adults: A 12-Year Review
2000
Diagnosis of recent and relapsed cases of human brucellosis by PCR assay
2003
Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas
2005
Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen
2004
Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome
2007
Vertebral osteomyelitis: eight years’ experience of 100 cases
2011
Evaluation of conservative treatment of non specific spondylodiscitis
2009
Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin
2006
Cervical Spinal Brucellosis with Epidural Abscess Causing Neurologic Deficit with Negative Serologic Tests
2011
How antibiotics kill bacteria: from targets to networks
2010 Standout
Activity and DNA contamination of commercial polymerase chain reaction reagents for the universal 16S rDNA real-time polymerase chain reaction detection of bacterial pathogens in blood
2008
Versatility of Aminoglycosides and Prospects for Their Future
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Multiple Measures of Magnesium Status Are Comparable in Mild Asthma and Control Subjects
2006
Silicosis
2012 Standout
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
2015
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Evaluation of Conventional Castaneda and Lysis Centrifugation Blood Culture Techniques for Diagnosis of Human Brucellosis
2004
Effective treatments in the management of brucellosis
2005
The Aminoglycosides
1999
Magnesium in Man: Implications for Health and Disease
2014 Standout
Efficacy of Gentamicin plus Doxycycline versus Streptomycin plus Doxycycline in the Treatment of Brucellosis in Humans
2006
Prevention of Laboratory-Acquired Brucellosis
2004
Zygomycetes in Human Disease
2000 Standout
PCR Technologies for Point of Care Testing: Progress and Perspectives
2017
The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable?
1997
Dynamic Kinetic Resolution Process Employing Haloalkane Dehalogenase
2011 StandoutNobel
Emergence of the trimethoprim resistance gene dfrD in Listeria monocytogenes BM4293
1997 StandoutNobel
Review of clinical and laboratory features of human <i>Brucellosis</i>
2007
Interventions for enhancing medication adherence
2008 Standout
Gold nanoparticle-based lateral flow assay for detection of staphylococcal enterotoxin B
2009
USE OF THE BRUCELLA IgM AND IgG FLOW ASSAYS IN THE SERODIAGNOSIS OF HUMAN BRUCELLOSIS IN AN AREA ENDEMIC FOR BRUCELLOSIS
2004
Prospective Evaluation of 140 Patients With Brucellosis in the Southern Region of Turkey
2007
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Treatment of Human Brucellosis with Rifampin plus Minocycline
2003
Laboratory Exposures to Brucellae and Implications for Bioterrorism
2005
Poly(d ,l -Lactide-Coglycolide) Particles Containing Gentamicin: Pharmacokinetics and Pharmacodynamics inBrucella melitensis- Infected Mice
2007
Real-Time Multiplex PCR Assay for Detection of Brucella spp., B. abortus , and B. melitensis
2004
Central Nervous System Infection with Listeria monocytogenes : 33 Yearsʼ Experience at a General Hospital and Review of 776 Episodes from the Literature
1998
Emerging Infectious Diseases in Mongolia
2003
Interventions for enhancing medication adherence
2014 Standout
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
EVALUATION OF BRUCELLOSIS BY PCR AND PERSISTENCE AFTER TREATMENT IN PATIENTS RETURNING TO THE HOSPITAL FOR FOLLOW-UP
2007
Human brucellosis: an overview
2003
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home
2006
Prosthetic Joint Infection
2014 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Clinical Differences Between Monomicrobial and Polymicrobial Vertebral Osteomyelitis
2016
Antibiotic Resistance in Listeria spp
1999 StandoutNobel
Detection of Brucellae in Blood Cultures
1999
Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates
2010
Possible implications of doxycycline-rifampin interaction for treatment of brucellosis
1994
Posttreatment Follow-Up of Brucellosis by PCR Assay
1999
Long-term Functional Outcome in Pyogenic Spinal Infection
2008
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment
2008
Evaluation of Different PCR Assays for Early Detection of Acute and Relapsing Brucellosis in Humans in Comparison with Conventional Methods
2007
Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients
2002
Serum Is the Preferred Clinical Specimen for Diagnosis of Human Brucellosis by PCR
2001
Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area
2006
Quinolones for Treatment of Human Brucellosis: Critical Review of the Evidence from Microbiological and Clinical Studies
2005
Works of Javier Solera being referenced
Azithromycin and Gentamicin Therapy for the Treatment of Humans with Brucellosis
2001
Use of Real-Time Quantitative Polymerase Chain Reaction to Monitor the Evolution of Brucella melitensis DNA Load During Therapy and Post-Therapy Follow-Up in Patients with Brucellosis
2006
Listeriosis in Patients Infected with Human Immunodificiency Virus
1990
New approaches to the antibiotic treatment of brucellosis
2005
Acute Cholecystitis Caused by Brucella melitensis: Case Report and Review
2001
Treatment of Human Brucellosis with Netilmicin and Doxycycline
1996
Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials
1993
Evaluación de dos pautas de quimioprofilaxis tuberculosa en pacientes infectados por el virus de la inmunodeficiencia humana
2000
Multivariate model for predicting relapse in human brucellosis
1998
A Randomized, Double-Blind Study to Assess the Optimal Duration of Doxycycline Treatment for Human Brucellosis
2004
Brucellar osteomyelitis involving prosthetic extra-articular hardware
1997
Clinical utility of a dipstick assay in patients with brucellosis: correlation with the period of evolution of the disease
2003
Brucellar Spondylitis: Review of 35 Cases and Literature Survey
1999
Real-time PCR detection chemistry
2014
Vertebral osteomyelitis: Long-term disability assessment and prognostic factors
2006
Comparison of three different PCR methods for detection ofBrucellaspp. in human blood samples
2002
Recognition and Optimum Treatment of Brucellosis
1997
Vertebral Osteomyelitis Caused by Streptococcus agalactiae
2000
Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations
2007
Epididymoorchitis Due toBrucella mellitensis:A Retrospective Study of 59 Patients
2001
Utility of an immunocapture-agglutination test and an enzyme-linked immunosorbent assay test against cytosolic proteins from Brucella melitensis B115 in the diagnosis and follow-up of human acute brucellosis
2006
Treatment of human brucellosis.
2001
[Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
1998
[Large silent abscess in the leg by Escherichia coli].
1999
ImmunochromatographicBrucella-Specific Immunoglobulin M and G Lateral Flow Assays for Rapid Serodiagnosis of Human Brucellosis
2003
Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks.
1995
[Brucellar sacroiliitis. A detailed review with an analysis of treatment efficacy].
1992
Treatment of human brucellosis with doxycycline and gentamicin
1997
Gene expression profiles predict treatment outcomes in Brucellosis
2016
[A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
1991
[Mucormycosis. The disease spectrum in 13 patients].
1990
[Estimation of surgical wound infection rates using a post-hospital surveillance program].
1997
Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas
1995
Diagnosis of human brucellosis using PCR
2004
Rapid Diagnosis of Human Brucellosis by Quantitative Real-Time PCR: a Case Report of Brucellar Spondylitis
2007
[Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis].
1994
PCR Assay for Diagnosis of Human Brucellosis
1999